Literature DB >> 20600213

Dietary quercetin exacerbates the development of estrogen-induced breast tumors in female ACI rats.

Bhupendra Singh1, Sarah M Mense, Nimee K Bhat, Sandeep Putty, William A Guthiel, Fabrizio Remotti, Hari K Bhat.   

Abstract

Phytoestrogens are plant compounds that structurally mimic the endogenous estrogen 17beta-estradiol (E(2)). Despite intense investigation, the net effect of phytoestrogen exposure on the breast remains unclear. The objective of the current study was to examine the effects of quercetin on E(2)-induced breast cancer in vivo. Female ACI rats were given quercetin (2.5 g/kg food) for 8 months. Animals were monitored weekly for palpable tumors, and at the end of the experiment, rats were euthanized, breast tumor and different tissues excised so that they could be examined for histopathologic changes, estrogen metabolic activity and oxidant stress. Quercetin alone did not induce mammary tumors in female ACI rats. However, in rats implanted with E(2) pellets, co-exposure to quercetin did not protect rats from E(2)-induced breast tumor development with 100% of the animals developing breast tumors within 8 months of treatment. No changes in serum quercetin levels were observed in quercetin and quercetin+E(2)-treated groups at the end of the experiment. Tumor latency was significantly decreased among rats from the quercetin+E(2) group relative to those in the E(2) group. Catechol-O-methyltransferase (COMT) activity was significantly downregulated in quercetin-exposed mammary tissue. Analysis of 8-isoprostane F(2alpha) (8-iso-PGF(2alpha)) levels as a marker of oxidant stress showed that quercetin did not decrease E(2)-induced oxidant stress. These results indicate that quercetin (2.5 g/kg food) does not confer protection against breast cancer, does not inhibit E(2)-induced oxidant stress and may exacerbate breast carcinogenesis in E(2)-treated ACI rats. Inhibition of COMT activity by quercetin may expose breast cells chronically to E(2) and catechol estrogens. This would permit longer exposure times to the carcinogenic metabolites of E(2) and chronic exposure to oxidant stress as a result of metabolic redox cycling to estrogen metabolites, and thus quercetin may exacerbate E(2)-induced breast tumors in female ACI rats. 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20600213      PMCID: PMC4006967          DOI: 10.1016/j.taap.2010.06.011

Source DB:  PubMed          Journal:  Toxicol Appl Pharmacol        ISSN: 0041-008X            Impact factor:   4.219


  67 in total

1.  Ovary-intact, but not ovariectomized female ACI rats treated with 17beta-estradiol rapidly develop mammary carcinoma.

Authors:  J D Shull; T J Spady; M C Snyder; S L Johansson; K L Pennington
Journal:  Carcinogenesis       Date:  1997-08       Impact factor: 4.944

2.  Rat strain-specific actions of 17beta-estradiol in the mammary gland: correlation between estrogen-induced lobuloalveolar hyperplasia and susceptibility to estrogen-induced mammary cancers.

Authors:  D M Harvell; T E Strecker; M Tochacek; B Xie; K L Pennington; R D McComb; S K Roy; J D Shull
Journal:  Proc Natl Acad Sci U S A       Date:  2000-03-14       Impact factor: 11.205

3.  2-Methoxymethylestradiol: a new 2-methoxy estrogen analog that exhibits antiproliferative activity and alters tubulin dynamics.

Authors:  R W Brueggemeier; A S Bhat; C J Lovely; H D Coughenour; S Joomprabutra; D H Weitzel; D D Vandre; F Yusuf; W E Burak
Journal:  J Steroid Biochem Mol Biol       Date:  2001-08       Impact factor: 4.292

4.  Estrogenic and antiestrogenic properties of resveratrol in mammary tumor models.

Authors:  K P Bhat; D Lantvit; K Christov; R G Mehta; R C Moon; J M Pezzuto
Journal:  Cancer Res       Date:  2001-10-15       Impact factor: 12.701

5.  Phytochemicals inhibit catechol-O-methyltransferase activity in cytosolic fractions from healthy human mammary tissues: implications for catechol estrogen-induced DNA damage.

Authors:  Majorie B M van Duursen; J Thomas Sanderson; Paul C de Jong; Marlies Kraaij; Martin van den Berg
Journal:  Toxicol Sci       Date:  2004-07-14       Impact factor: 4.849

6.  Suppression of 7,12-dimethylbenz(a)anthracene-induced mammary carcinogenesis in rats by resveratrol: role of nuclear factor-kappaB, cyclooxygenase 2, and matrix metalloprotease 9.

Authors:  Sanjeev Banerjee; Carlos Bueso-Ramos; Bharat B Aggarwal
Journal:  Cancer Res       Date:  2002-09-01       Impact factor: 12.701

Review 7.  Potential toxicity of flavonoids and other dietary phenolics: significance for their chemopreventive and anticancer properties.

Authors:  Giuseppe Galati; Peter J O'Brien
Journal:  Free Radic Biol Med       Date:  2004-08-01       Impact factor: 7.376

8.  Inhibition of catechol O-methyltransferase-catalyzed O-methylation of 2- and 4-hydroxyestradiol by quercetin. Possible role in estradiol-induced tumorigenesis.

Authors:  B T Zhu; J G Liehr
Journal:  J Biol Chem       Date:  1996-01-19       Impact factor: 5.157

Review 9.  Breast cancer.

Authors:  G Ursin; L Bernstein; M C Pike
Journal:  Cancer Surv       Date:  1994

10.  Estrogen-induced breast cancer: alterations in breast morphology and oxidative stress as a function of estrogen exposure.

Authors:  Sarah M Mense; Fabrizio Remotti; Ashima Bhan; Bhupendra Singh; Mahmoud El-Tamer; Tom K Hei; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2008-07-01       Impact factor: 4.219

View more
  20 in total

Review 1.  Influence of berry polyphenols on receptor signaling and cell-death pathways: implications for breast cancer prevention.

Authors:  Harini S Aiyer; Anni M Warri; Denzel R Woode; Leena Hilakivi-Clarke; Robert Clarke
Journal:  J Agric Food Chem       Date:  2012-02-22       Impact factor: 5.279

2.  Risk of prostate cancer in African-American men: Evidence of mixed effects of dietary quercetin by serum vitamin D status.

Authors:  C J Paller; Y M Kanaan; D A Beyene; T J Naab; R L Copeland; H L Tsai; N F Kanarek; T S Hudson
Journal:  Prostate       Date:  2015-06-05       Impact factor: 4.104

3.  Superoxide dismutase 3 is induced by antioxidants, inhibits oxidative DNA damage and is associated with inhibition of estrogen-induced breast cancer.

Authors:  Bhupendra Singh; Hari K Bhat
Journal:  Carcinogenesis       Date:  2012-10-01       Impact factor: 4.944

Review 4.  Role of dietary bioactive natural products in estrogen receptor-positive breast cancer.

Authors:  Min Ji Bak; Soumyasri Das Gupta; Joseph Wahler; Nanjoo Suh
Journal:  Semin Cancer Biol       Date:  2016-03-22       Impact factor: 15.707

5.  Dose-dependent benefits of quercetin on tumorigenesis in the C3(1)/SV40Tag transgenic mouse model of breast cancer.

Authors:  Jl Steiner; Jm Davis; Jl McClellan; Rt Enos; Ja Carson; R Fayad; M Nagarkatti; Ps Nagarkatti; D Altomare; Ke Creek; Ea Murphy
Journal:  Cancer Biol Ther       Date:  2014       Impact factor: 4.742

6.  MicroRNA-93 regulates NRF2 expression and is associated with breast carcinogenesis.

Authors:  Bhupendra Singh; Amruta M Ronghe; Anwesha Chatterjee; Nimee K Bhat; Hari K Bhat
Journal:  Carcinogenesis       Date:  2013-03-14       Impact factor: 4.944

Review 7.  Rat models of 17β-estradiol-induced mammary cancer reveal novel insights into breast cancer etiology and prevention.

Authors:  James D Shull; Kirsten L Dennison; Aaron C Chack; Amy Trentham-Dietz
Journal:  Physiol Genomics       Date:  2018-01-26       Impact factor: 3.107

8.  4-(E)-{(p-tolylimino)-methylbenzene-1,2-diol}, 1 a novel resveratrol analog, differentially regulates estrogen receptors α and β in breast cancer cells.

Authors:  Amruta Ronghe; Anwesha Chatterjee; Bhupendra Singh; Prasad Dandawate; Fatma Abdalla; Nimee K Bhat; Subhash Padhye; Hari K Bhat
Journal:  Toxicol Appl Pharmacol       Date:  2016-03-09       Impact factor: 4.219

9.  Resveratrol inhibits estrogen-induced breast carcinogenesis through induction of NRF2-mediated protective pathways.

Authors:  Bhupendra Singh; Rivka Shoulson; Anwesha Chatterjee; Amruta Ronghe; Nimee K Bhat; Daniel C Dim; Hari K Bhat
Journal:  Carcinogenesis       Date:  2014-06-03       Impact factor: 4.944

Review 10.  Cancer prevention with promising natural products: mechanisms of action and molecular targets.

Authors:  Poyil Pratheeshkumar; Chakkenchath Sreekala; Zhuo Zhang; Amit Budhraja; Songze Ding; Young-Ok Son; Xin Wang; Andrew Hitron; Kim Hyun-Jung; Lei Wang; Jeong-Chae Lee; Xianglin Shi
Journal:  Anticancer Agents Med Chem       Date:  2012-12       Impact factor: 2.505

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.